News

October 19, 2011—Pneumococcal Conjugate Vaccine Symposium. PATH sponsored. Beijing, China Fina BioSolutions presents at MinHai Biotech Beijing and Chengdu Biological Institute on bioconjugation chemistry.

September 29, 2011—Andrew Lees will be speaking on Membrane Chromatography for the purification of Conjugate Vaccines. Sartorius Downstream Technical Forum, Rockville, MD

June 8, 2011—Downstream Processing & Protein Purification Workshop University of Maryland, College Park Biotechnology Research and Education Program

October 27, 2010—Andrew Lees, Scientific Director of Fina BioSolutions, will be speaking at the IBC 7th Annual Early Development Forum, Preclinical Scale Bioprocessing Meeting, Boston, MA, Nov 1-3, 2010. Membrane Chromatography for the Purification of Conjugate Vaccines.

May 18, 2010—Andrew Lees, Scientific Director of Fina BioSolutions, has been appointed Associate Professor of Medicine, part time, to the faculty of the Department of Medicine at the University of Maryland School of Medicine, Baltimore, Maryland.

September 18, 2009—Fina BioSolutions announces an upcoming webinar: Title: Enhancing Process Economics and Improving Product Purity Date: Thursday, September 24, 2009 Time: 2:00 PM - 3:00 PM EDT Space is limited - reserve your Webinar seat now. After registering you will receive a confirmation email containing information about joining the Webinar. Event Information A presentation and discussion led by: Andrew continue→

July 1, 2009—Andrew Lees, Scientific Director of Fina BioSolutions, joins the scientific advisory board of BioExcellence India. He will be assisting with bioprocessing training and curriculum development. Bioexcellence India, Foundation for Biotechnology Education Research and Training is a not for profit organization incepted for promotion of biotechnology and allied sciences. The mission continue→

May 2, 2009—Fina BioSolutions partners with U.S. VirGene to provide cloning and molecular biology services. US VirGene Inc. is a bio-tech company devoted to the development of novel application for bio-products in the food and pharmaceutical industry. More specifically, the company seeks to discover new uses for bio-enzymes in the area continue→

May 1, 2009—Stephanie Channing joins Fina Bio to assist with the development of conjugate vaccines.

March 1, 2008—Jesse Edwards, Ph.D., joins Fina Bio as Director of Protein Purification. Dr. Edwards, formerly… of Kemp Biotech,